Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...

Panadol has unveiled sub-brand Panmigrol, aimed at tackling migraine pain.

Securities exhibited a bullish stance on Axsome Therapeutics (NASDAQ:AXSM), currently trading at $106.46 with a market cap of $5.16 billion, as analyst Graig Suvannavejh increased the company's price ...

You know those days where everything feels overwhelming? The grocery store lights are blinding, your sweater feels like ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS ...

Women taking the beta blocker propranolol to ward off migraines have a lower risk of strokes caused by blood clots, according ...